An experimental HIV vaccine based on mRNA -- the same platform technology used in two highly effective COVID-19 vaccines -- shows promise in mice and non-human primates, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
https://www.sciencedaily.com/releases/2021/12/211209124236.htm